Identification of a potent and selective oxytocin antagonist, from screening a fully encoded differential release combinatorial chemical library

Bioorganic and Medicinal Chemistry Letters

Volumn 11, Issue 10, 2001, Pages 1297-1300

  Evans, Brian ^a   Pipe, Adrian ^a   Clark, Liz ^a   Banks, Martyn ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; GW 405212X; OXYTOCIN ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; COMBINATORIAL CHEMISTRY; DRUG IDENTIFICATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS;

ANIMALS; BENZODIAZEPINES; CHO CELLS; COMBINATORIAL CHEMISTRY TECHNIQUES; CRICETINAE; DRUG EVALUATION, PRECLINICAL; HUMANS; INHIBITORY CONCENTRATION 50; OXYTOCIN; PEPTIDE LIBRARY; RECEPTORS, OXYTOCIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0035927236     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(01)00201-3     Document Type: Article

References (14)

1. Lewell X.Q., Judd D.B., Watson S.P., Hann M.M. J. Chem. Inf. Comput. Sci. 38:1998;511.
2. Houston J.G., Banks M. Curr. Opin. Biotechnol. 8:1997;734.
3. Furka A., Sebestyen M., Asgedom M., Dibo G. Int. J. Pept. Protein Res. 37:1991;487.
4. Needels M., Sugarman J. Comb. Chem. Mol. Diversity Drug Discovery. 1998;339.
5. Gallop M.A., Barrett R.W., Dower W.J., Fodor S.P., Gordon E.M.J. J. Med. Chem. 37:1994;1233.
6. Freier S.M., Konings D.A.M., Wyatt J.R., Ecker D.J. J. Med. Chem. 38:1995;344.
7. Salmon S.E., Lam K.S., Lebl M., Kandola A., Khattri P.S., Wade S., Patek M., Kocis P., Krchnak V., Thorpe D., Felder S. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11708.
8. Cardno M., Bradley M. Tetrahedron Lett. 37:1996;135.
9. Affleck, R. L.; Hobbs, D.; Feygin, I.; Kirk, G. L.; Connelly, J. A.; Zhaq, N.; Mueller, J. P.; Kieselbach, P. WO 99/08869.
10. Ni Z.-J., Maclean D., Holmes C.P., Gallop M.A. Methods Enzymol. 267:1996;261.
11. 3H]-oxytocin this membrane-receptor complex was incubated in the presence of cleaved compounds at room temperature. After 4 h, DPM was counted for 1 min per well using a Wallac Trilux scintillation counter, with the appropriate colour quench correction. Nonspecific binding was determined in the presence of 10 μM oxytocin.
12. Abdelmoty I., Albericio F., Carpino L.A., Foxman B.M., Kates S.A. Lett. Pept. Sci. 1:1994;57.
13. Burgess K., Liaw A.I., Wang N. J. Med. Chem. 37:1994;2985.
14. Bead cup plates are modified micro-titre plates pierced to allow liquid to be spun through a hole and yet be small enough to retain the bead in the well. Neutrally buoyant fluid is removed by centrifugation. The beads are washed with water that is removed by centrifugation and are then dried in a vacuum centrifuge. Cleavage of compounds from the resin is carried out in the well. The hole is small enough that cleavage medium is retained in the well until the plates are placed in a centrifuge. After 2 h of cleavage time, the medium is spun through into a collection plate.